Chymotrypsin and Trypsin
- 13 April 1961
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 264 (15) , 764-765
- https://doi.org/10.1056/nejm196104132641509
Abstract
AT the present time there is general concern over the merits of various orally prescribed enzymatic preparations. Most of the available clinical data are inadequately controlled. This is mainly so because of the almost impossible task of setting up proper controls in situations in which these preparations are used clinically. Because of the growing importance of this type of therapy and uneasiness over the inadequacy of available clinical data certain basic facts become highly important. Not much information is available concerning the absorption and inactivation of most of these preparations in man. Such data must be available before anything like . . .Keywords
This publication has 8 references indexed in Scilit:
- Uptake of Small Resin Particles (1–5µ Diameter) by the Alimentary Canal of the CalfNature, 1960
- Crystalline Acid-labile Trypsin Inhibitor from Bovine Blood PlasmaJournal of Biological Chemistry, 1960
- Some Properties of Trypsin Inhibitor of Pancreatic JuiceExperimental Biology and Medicine, 1958
- Proteolytic Enzymes. HI. Circulating Esterase Activities after Parenteral Trypsin and Chymotrypsin in Rabbits.Experimental Biology and Medicine, 1956
- Pancreatic trypsin inhibitor. 1. Preparation and propertiesBiochemical Journal, 1953
- Investigations of di(acetylhydroxyphenyl)isatin. I. Quantitative excretion in ratsJournal of the American Pharmaceutical Association (Scientific ed.), 1951
- Über den Trypsin-Inhibitor des Blutes. Dritte Mitteilung zur Kenntnis des Plasmatrypsinsystems.Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1938
- I. Influence of Eggwhite upon the Absorption of Bacteria from the Intestinal Tract.Experimental Biology and Medicine, 1931